A decades-old glaucoma drug tossed aside by Pfizer gets a new life at a small biotech

Months ago, Pfizer made a grim announcement that it would stop manufacturing phospholine iodide, its decades-old “miracle drug” for a rare form of glaucoma. The pharma said its inventory would run dry by May 2021, leaving some patients with few options short of surgery.